Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance
Governance
Management, auditors, ratings and legal matters
| Filed | Kind | What the filing says |
|---|---|---|
| 05 Nov 2026 | Management change | Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with Limited Review Reports enclosed. Board approved an interim dividend for FY 2026-27 of Rs. 1.50 per share on face value of Rs. 1 per share, with record date Friday,... NSE copy |
| 05 Nov 2026 | Management change | Astral Limited filed the outcome of its board meeting held on November 5, 2026, which approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with limited review reports. The board approved an interim dividend for FY 2026-27 of Rs. 1.50 per... NSE copy |
| 29 Jul 2026 | Legal or regulatory | Astral Limited's board met on July 29, 2026 and withdrew the proposed Composite Scheme of Arrangement, under which the Chemical Business was to be demerged. An Independent Consultant, appointed to review the scheme, recommended not proceeding with it in its present form given the current scale of the Chemical... NSE copy |
| 29 Jul 2026 | Legal or regulatory | Astral Limited filed the outcome of its board meeting held on July 29, 2026, under SEBI LODR Regulation 30. An Independent Consultant appointed to review the Composite Scheme of Arrangement recommended not proceeding with the scheme in its present form, given the current scale of the Chemical Business. The Board... NSE copy |
| 05 Jul 2026 | Legal or regulatory | Astral Limited's board met on July 5, 2026 and reviewed the Composite Scheme of Arrangement with Astral Chemie Limited and Al-Aziz Plastics Private Limited, approved on June 25, 2026. The board decided to undertake a comprehensive independent review of the Scheme after feedback from various stakeholders following... NSE copy |
| 05 Jul 2026 | Legal or regulatory | Astral Limited filed the outcome of its board meeting held on July 5, 2026, which ran from 2:00 PM to 2:45 PM. The board decided to undertake a comprehensive independent review of the Composite Scheme of Arrangement amongst Astral Limited, Astral Chemie Limited and Al-Aziz Plastics Private Limited, approved on June... NSE copy |
| 25 Jun 2026 | Legal or regulatory | Board of Astral Limited approved a Composite Scheme of Arrangement under Sections 230 to 233 of the Companies Act, 2013, on June 25, 2026. The Scheme provides for demerger of the Chemicals Business Undertaking of Astral Limited into Astral Chemie Limited (formerly Astral Coatings Private Limited), and amalgamation... NSE copy |
| 25 Jun 2026 | Legal or regulatory | Board of Astral Limited approved a Composite Scheme of Arrangement under Sections 230 to 233 of the Companies Act, 2013, involving Astral Chemie Limited (formerly Astral Coatings Private Limited) and Al-Aziz Plastics Private Limited. The Scheme provides for demerger of the Chemicals Business Undertaking of Astral... NSE copy |
| 18 May 2026 | Management change | Astral Limited's board met on May 18, 2026 and approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with unmodified auditor opinion. The board recommended a final dividend of Rs. 2.50 per equity share (face value Rs. 1) for the year ended March 31, 2026,... NSE copy |
| 18 May 2026 | Management change | Astral Limited's board met on May 18, 2026 and approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with unmodified auditor opinions. The board recommended a final dividend of Rs. 2.50 per equity share of Rs. 1 each for FY2026, subject to member approval at... NSE copy |
| 05 Feb 2026 | Legal or regulatory | Board of Astral Limited approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 at a meeting held February 5, 2026. Standalone revenue from operations for Q3 FY26 was Rs. 13,816 million (Rs. 14,161 million in Q2 FY26); standalone net profit was Rs.... NSE copy |
| 21 May 2025 | Management change | Board of Directors of Astral Limited, meeting held on 21 May 2025, approved audited standalone and consolidated financial results for the quarter and year ended 31 March 2025, with an unmodified audit opinion. The Board recommended a final dividend of Rs. 2.25 per equity share of Re. 1 face value for FY 2024-25,... NSE copy |
| 21 May 2025 | Management change | Astral Limited's board, at its meeting on 21 May 2025, approved audited standalone and consolidated financial results for the quarter and year ended 31 March 2025, with an unmodified audit opinion from the statutory auditors. The board recommended a final dividend of Rs. 2.25 per equity share of Re. 1 face value... NSE copy |
| 21 May 2025 | Management change | Astral Limited filed the outcome of its board meeting held on 21 May 2025, approving audited standalone and consolidated financial results for the quarter and year ended 31 March 2025, with an unmodified audit opinion. The board recommended a final dividend of Rs. 2.25 per equity share of Re. 1 face value for... NSE copy |
Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (14 in all). A list of what was filed, not a judgement of the company.